EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tamoxifen induced cardiac damage via the IL-6/p-STAT3/PGC-1α pathway

Tingting Meng, Dan Zhang, Yu Zhang, Peng Tian, Jianlin Chen, Anbang Liu, Ying Li, Chunhong Song, Yan Zheng, Guohai Su

International Immunopharmacology · 2023-12 · 125 · 110978

DOI: 10.1016/j.intimp.2023.110978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-12. Verfasst von Tingting Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Interleukin-6, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Shandong First Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tamoxifen (TAM) is an effective anticancer drug for breast and ovarian cancer. However, increased risk of cardiotoxicity is a long-term clinical problem associated with TAM, while the underlying mechanisms remain unclear. Here, we performed experiments in cardiomyocytes and tumor-bearing or nontumor-bearing mice, and demonstrated that TAM induced cardiac injury via the IL-6/p-STAT3/PGC-1α/IL-6 feedback loop, which is responsible for reactive oxygen species (ROS) accumulation. Compared with non-tumor bearing mice, tumor-bearing mice showed stronger cardiac toxicity after TAM injection, although there was no significant difference. In vitro experiments demonstrated STAT3 phosphorylation inhibitor can increase PGC-1α expression and protect cardiomyocyte via decreasing ROS. Since tumor has higher STAT3 phosphorylation and IL-6 expression level, our research results indicated combining TAM and STAT3 inhibitor might be an effective treatment strategy which can provide both tumor killing and cardioprotective function. Further in vivo research is needed to fully elucidate the effect and mechanisms of the combination therapy of TAM and STAT3 inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-6NeoplasmsMiceAnimalsReactive Oxygen SpeciesTamoxifenMyocytes, CardiacCardiotoxicity

Stichwörter der Autor:innen

ApoptosisIL-6PGC-1αTamoxifenTumor-bearing mice

Substanzen

Reactive Oxygen SpeciesInterleukin-6Tamoxifen

Autor:innen und Institutionen

  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Jinan Central Hospital, Jinan, Shandong, China.
  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; Research Center of Translational Medicine, Jinan Central Hospital, Shandong University…
  • Research Center of Translational Medicine, Jinan Central Hospital, Weifang Medical University, Weifang, China.
  • Laboratory Animal Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Electronic address: gttstg@163.com.

Förderung

  • Natural Science Foundation of Shandong Province
  • Shandong First Medical University

Zitieren

APA

Meng, T., Zhang, D., Zhang, Y., Tian, P., Chen, J., Liu, A., Li, Y., Song, C., Zheng, Y., & Su, G. (2023). Tamoxifen induced cardiac damage via the IL-6/p-STAT3/PGC-1α pathway. International Immunopharmacology, 125, 110978. https://doi.org/10.1016/j.intimp.2023.110978

Vancouver

Meng T, Zhang D, Zhang Y, Tian P, Chen J, Liu A, et al. Tamoxifen induced cardiac damage via the IL-6/p-STAT3/PGC-1α pathway. International Immunopharmacology. 2023;125:110978. doi:10.1016/j.intimp.2023.110978

BibTeX
@article{Meng2023,
  author = {Meng, Tingting and Zhang, Dan and Zhang, Yu and Tian, Peng and Chen, Jianlin and Liu, Anbang and Li, Ying and Song, Chunhong and Zheng, Yan and Su, Guohai},
  title = {Tamoxifen induced cardiac damage via the IL-6/p-STAT3/PGC-1α pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {125},
  pages = {110978},
  doi = {10.1016/j.intimp.2023.110978}
}
Kostenlos starten →